ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 118 filers reported holding ACCELERON PHARMA INC in Q1 2015. The put-call ratio across all filers is 0.99 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,614,000 | +9938.9% | 21,002 | +7400.7% | 0.00% | – |
| Q4 2020 | $36,000 | -89.4% | 280 | -96.1% | 0.00% | -100.0% |
| Q1 2019 | $339,000 | +3.0% | 7,269 | -3.7% | 0.00% | +33.3% |
| Q4 2018 | $329,000 | +181.2% | 7,548 | +140.8% | 0.00% | +200.0% |
| Q3 2017 | $117,000 | +680.0% | 3,134 | +458.6% | 0.00% | – |
| Q1 2016 | $15,000 | +400.0% | 561 | +819.7% | 0.00% | – |
| Q4 2015 | $3,000 | -98.8% | 61 | -99.1% | 0.00% | -100.0% |
| Q1 2015 | $247,000 | +4016.7% | 6,479 | +3139.5% | 0.00% | – |
| Q3 2014 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |